Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma - Hiroishi, K; Eguchi, J; Baba, T (J Gastroenterol, 2010)
et al.